Pediatrix Medical Group, Inc. (NYSE:MD) Position Increased by Deutsche Bank AG

Deutsche Bank AG boosted its position in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 53.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 74,023 shares of the company's stock after purchasing an additional 25,663 shares during the quarter. Deutsche Bank AG owned approximately 0.09% of Pediatrix Medical Group worth $971,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of MD. Nomura Asset Management Co. Ltd. raised its holdings in shares of Pediatrix Medical Group by 95.3% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after purchasing an additional 1,220 shares during the period. Parkside Financial Bank & Trust grew its stake in shares of Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock valued at $51,000 after buying an additional 1,040 shares in the last quarter. AlphaQuest LLC grew its stake in shares of Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock valued at $66,000 after buying an additional 2,012 shares in the last quarter. Smartleaf Asset Management LLC grew its stake in shares of Pediatrix Medical Group by 750.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock valued at $91,000 after buying an additional 6,090 shares in the last quarter. Finally, Tower Research Capital LLC TRC grew its stake in shares of Pediatrix Medical Group by 218.0% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock valued at $98,000 after buying an additional 5,104 shares in the last quarter. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

MD has been the subject of a number of recent analyst reports. Truist Financial lowered their price objective on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a research note on Friday, April 11th. UBS Group lowered their price objective on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a research note on Monday, May 12th. Finally, Macquarie raised their price objective on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research note on Thursday, May 8th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $16.67.

Pediatrix Medical Group Stock Performance

NYSE:MD traded up $0.04 during trading hours on Friday, reaching $14.27. 354,696 shares of the stock were exchanged, compared to its average volume of 865,107. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. The firm has a 50 day simple moving average of $13.73 and a 200-day simple moving average of $14.05. Pediatrix Medical Group, Inc. has a 52 week low of $6.62 and a 52 week high of $17.67. The stock has a market capitalization of $1.23 billion, a P/E ratio of -11.86, a P/E/G ratio of 1.74 and a beta of 1.26.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, topping analysts' consensus estimates of $0.25 by $0.08. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The company had revenue of $458.36 million for the quarter, compared to the consensus estimate of $451.44 million. During the same quarter last year, the business posted $0.20 EPS. Pediatrix Medical Group's quarterly revenue was down 7.4% compared to the same quarter last year. As a group, sell-side analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.